🇺🇸 FDA
Patent

US 12180509

Methods for reprograming non-pluripotent cells into pluripotent stem cells

granted A61KA61K35/545A61K9/0019

Quick answer

US patent 12180509 (Methods for reprograming non-pluripotent cells into pluripotent stem cells) held by BeiHao Stem Cell and Regenerative Medicine Research Institute Co., Ltd. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BeiHao Stem Cell and Regenerative Medicine Research Institute Co., Ltd.
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K35/545, A61K9/0019